Insights

Loading spinner
Gathering insights about Glycostem Therapeutics

Glycostem Therapeutics Tech Stack

Glycostem Therapeutics uses 8 technology products and services including Drupal, Apple iCloud Mail, yepnope.js, and more. Explore Glycostem Therapeutics's tech stack below.

  • Drupal
    Content Management System
  • Apple iCloud Mail
    Email
  • yepnope.js
    Javascript Frameworks
  • Google Maps
    Maps
  • reCAPTCHA
    Security
  • Google Analytics
    Web Analytics
  • Apache
    Web Servers
  • X-UA-Compatible
    Web Tools And Plugins

Media & News

Glycostem Therapeutics's Email Address Formats

Glycostem Therapeutics uses at least 1 format(s):
Glycostem Therapeutics Email FormatsExamplePercentage
First@glycostem.comJohn@glycostem.com
48%
FirstL@glycostem.comJohnD@glycostem.com
3%
First.Last@glycostem.comJohn.Doe@glycostem.com
1%
First@glycostem.comJohn@glycostem.com
48%

Frequently Asked Questions

Where is Glycostem Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Glycostem Therapeutics's main headquarters is located at Kloosterstraat 9, Oss, 5349 AB, NL. The company has employees across 1 continents, including Europe.

What is Glycostem Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Glycostem Therapeutics's official website is glycostem.com and has social profiles on LinkedIn.

What is Glycostem Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Glycostem Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Glycostem Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2025, Glycostem Therapeutics has approximately 25 employees across 1 continents, including Europe. Key team members include Cso: J. S.Chief Development Officer: V. H.Chief Medical Officer: D. H.. Explore Glycostem Therapeutics's employee directory with LeadIQ.

What industry does Glycostem Therapeutics belong to?

Minus sign iconPlus sign icon
Glycostem Therapeutics operates in the Biotechnology Research industry.

What technology does Glycostem Therapeutics use?

Minus sign iconPlus sign icon
Glycostem Therapeutics's tech stack includes DrupalApple iCloud Mailyepnope.jsGoogle MapsreCAPTCHAGoogle AnalyticsApacheX-UA-Compatible.

What is Glycostem Therapeutics's email format?

Minus sign iconPlus sign icon
Glycostem Therapeutics's email format typically follows the pattern of First@glycostem.com. Find more Glycostem Therapeutics email formats with LeadIQ.

When was Glycostem Therapeutics founded?

Minus sign iconPlus sign icon
Glycostem Therapeutics was founded in 2007.

Glycostem Therapeutics

Biotechnology ResearchNetherlands11-50 Employees

Glycostem Therapeutics is a Dutch biotech company established in 2007.
Glycostem Therapeutics has developed the world's first GMP compliant NK cell platform that is ready for industrial scale-up.

Section iconCompany Overview

Headquarters
Kloosterstraat 9, Oss, 5349 AB, NL
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
11-50

Section iconFunding & Financials

  • $1M

    Glycostem Therapeutics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Glycostem Therapeutics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.